Comparative efficacy of chemical and botanical pediculicides in Thailand and 4% dimeticone against head louse, Pediculus humanus capitis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
04
2023
accepted:
08
06
2023
medline:
26
6
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
epublish
Résumé
Head louse infestations remain a global public-health concern due to increased resistance of lice to artificial pediculicides. In Thailand, there is a lack of comparative data on the current efficacy of pediculicides for treating head lice. In this study, we explored the status of botanical and toxic synthetic pediculicides with that of 4% dimeticone liquid gel for treating head lice in Thailand. The ex-vivo pediculicidal activity of various pediculicidal shampoos available at drugstores in Thailand was assessed and compared with that of 4% dimeticone liquid gel. The shampoos chosen were based on active ingredients toxic to lice (1% permethrin, 0.6% carbaryl, 0.15% Stemona root crude extract, or mixed plant extracts), whereas dimeticone acts physically on lice. We found that exposure to 4% dimeticone liquid gel following the manufacturer's instructions completely killed 100% of head lice in 15 min, whereas other pediculicide products failed to kill the great majority of head lice, whether treatment was for 10 min (resulting in 0% to 50.0% mortality) or 30 min (resulting in 17.0% to 60.0% mortality). We also extended a clinical assessment to confirm the efficacy of 1% permethrin for treating head lice in infested schoolchildren. In this clinical assessment, none of the 26 children treated with 1% permethrin shampoo achieved a cure after two applications. These results highlight that 4% dimeticone demonstrated a higher ex-vivo pediculicidal efficacy compared to both chemical and botanical pediculicides in Thailand. Conversely, 1% permethrin showed low efficacy in both laboratory and clinical assessments. Given its physical mode of action, 4% dimeticone merits consideration as an alternative treatment option for lice in Thailand, particularly in cases where treatment with toxic pediculicides has proven ineffective.
Identifiants
pubmed: 37352268
doi: 10.1371/journal.pone.0287616
pii: PONE-D-23-11571
pmc: PMC10289457
doi:
Substances chimiques
Permethrin
509F88P9SZ
dimethicone
92RU3N3Y1O
Insecticides
0
Dermatologic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0287616Informations de copyright
Copyright: © 2023 Yingklang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest. Any mention of the trademark in this document is purely informational and is not meant to be used for profit or to infringe upon the legal rights of the trademark’s owner. This article is simply distributed for scientific purpose.
Références
Int J Antimicrob Agents. 2018 Nov;52(5):593-598
pubmed: 30055248
Drugs Context. 2022 Mar 14;11:
pubmed: 35371269
Nat Rev Genet. 2000 Dec;1(3):218-26
pubmed: 11252751
Acta Trop. 2020 Apr;204:105362
pubmed: 32006522
J Am Acad Dermatol. 2020 Mar;82(3):551-569
pubmed: 31306729
Med Vet Entomol. 2008 Sep;22(3):264-72
pubmed: 18816275
Pediatrics. 2022 Oct 1;150(4):
pubmed: 36156158
Pediatr Dermatol. 2020 Jan;37(1):86-92
pubmed: 31642120
PLoS One. 2016 Jun 10;11(6):e0156853
pubmed: 27286033
Korean J Parasitol. 2019 Oct;57(5):499-504
pubmed: 31715690
BMC Pharmacol. 2009 Feb 20;9:3
pubmed: 19232080
BMC Dermatol. 2013 Apr 01;13:5
pubmed: 23548062
Parasit Vectors. 2020 Apr 7;13(1):177
pubmed: 32264930
Parasit Vectors. 2015 Feb 26;8:127
pubmed: 25889008
Infect Genet Evol. 2021 Jul;91:104825
pubmed: 33775906
Am Fam Physician. 2019 May 15;99(10):635-642
pubmed: 31083883
Parasite. 2018;25:8
pubmed: 29521258
J Am Acad Dermatol. 2007 Feb;56(2):250-6
pubmed: 17147968
Emerg Infect Dis. 2008 Sep;14(9):1493-4
pubmed: 18760032
BMC Public Health. 2009 Dec 01;9:441
pubmed: 19951427
Parasit Vectors. 2019 Jun 7;12(1):290
pubmed: 31174587
Pest Manag Sci. 2010 Sep;66(9):1031-40
pubmed: 20564731
Front Cell Infect Microbiol. 2020 Jan 21;9:474
pubmed: 32039050
PLoS Negl Trop Dis. 2020 Dec 16;14(12):e0008955
pubmed: 33326440
Int J Dermatol. 2021 Mar;60(3):272-280
pubmed: 32767380
BMC Dermatol. 2019 Sep 12;19(1):13
pubmed: 31510998
Infect Genet Evol. 2014 Apr;23:209-17
pubmed: 24524985
J Med Entomol. 2019 Oct 28;56(6):1698-1703
pubmed: 31219149
Pharmaceutics. 2022 Nov 10;14(11):
pubmed: 36365251
PLoS Pathog. 2013;9(11):e1003724
pubmed: 24244157
BMC Pediatr. 2015 Jun 20;15:70
pubmed: 26092045
Environ Sci Pollut Res Int. 2021 Jan;28(3):3506-3514
pubmed: 32918266
Front Biosci. 2008 Jan 01;13:1240-9
pubmed: 17981626
Mol Phylogenet Evol. 2008 Jun;47(3):1203-16
pubmed: 18434207
Parasitol Res. 2020 Oct;119(10):3125-3143
pubmed: 32803332
BMC Res Notes. 2011 Jan 25;4:15
pubmed: 21266024